Academic · Private company
OHSU Knight Cancer Institute
Track this companyFree. Adds OHSU Knight Cancer Institute to your Dealase workspace and tells you when its record changes.
Clinical trials2525 recruiting or active
Pipeline programs0None found yet
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Clinical trials25
- Low-Dose Sirolimus for the Treatment of RUNX1 Familial Platelet DisorderPHASE1 · RECRUITING · started Oct 5, 2026ClinicalTrials.gov NCT07844694 · fetched Nov 12, 2026
- Intraoperative Methadone for the Management of Postoperative Pain in Patients With Head and Neck CancersPHASE4 · RECRUITING · started Sep 22, 2026ClinicalTrials.gov NCT07857655 · fetched Nov 12, 2026
- An Exercise Intervention for Improving Mental and Physical Health in Patients With Primary Brain Tumors and Their Caregivers, ET-NEURO TrialNA · RECRUITING · started Aug 24, 2026ClinicalTrials.gov NCT07278440 · fetched Nov 12, 2026
- Mammogram Pretreatment With Ulipristal AcetatePHASE2 · RECRUITING · started Aug 21, 2026ClinicalTrials.gov NCT07434128 · fetched Nov 12, 2026
- Safety and Efficacy of a Single Dose of Gruticibart to Prevent CRTPHASE2 · RECRUITING · started Aug 6, 2026ClinicalTrials.gov NCT07498517 · fetched Nov 12, 2026
- Morning Versus Afternoon Administration of Immunotherapy for the Treatment of Advanced or Metastatic Solid Tumors, The Knight SHIFT StudyPHASE4 · RECRUITING · started Apr 24, 2026ClinicalTrials.gov NCT07405086 · fetched Nov 12, 2026
- Ruxolitinib With Azacitidine Maintenance for the Treatment of Patients With Acute Myeloid Leukemia Undergoing Reduced Intensity Allogeneic Stem Cell TransplantationPHASE1 · RECRUITING · started Apr 21, 2026ClinicalTrials.gov NCT07548983 · fetched Nov 12, 2026
- OMO-103 for the Treatment of Locally Advanced or Metastatic Pancreatic Ductal AdenocarcinomaEARLY_PHASE1 · RECRUITING · started Jan 27, 2026ClinicalTrials.gov NCT07089940 · fetched Nov 12, 2026
- Induction and Consolidation With Fludarabine, Cytarabine, Idarubicin, and Venetoclax for the Treatment of Acute Myeloid LeukemiaPHASE2 · RECRUITING · started Dec 12, 2025ClinicalTrials.gov NCT07228273 · fetched Nov 12, 2026
- Intrathecal Cytarabine, Methotrexate, and Hydrocortisone for the Prevention of High-Grade Chimeric Antigen Receptor T-Cell-Associated Neurotoxicity SyndromePHASE2 · RECRUITING · started Jun 4, 2025ClinicalTrials.gov NCT06895473 · fetched Nov 12, 2026
- Vaccine Responses in Patient With Multiple Myeloma and Non-Hodgkin Lymphoma After CAR-T TreatmentRECRUITING · started Mar 10, 2025ClinicalTrials.gov NCT06784167 · fetched Nov 12, 2026
- Venetoclax in Combination With Cladribine and Cytarabine Alternating With Azacitidine Plus Venetoclax for the Treatment of Newly Diagnosed Monocytic AML and Active Signaling Mutated AMLPHASE2 · RECRUITING · started Jan 3, 2025ClinicalTrials.gov NCT06504459 · fetched Nov 12, 2026
- Evaluation of the Change in PSMA Expression in Prostate Cancer in Response to Hormonal TherapyPHASE4 · RECRUITING · started Jun 25, 2024ClinicalTrials.gov NCT05919329 · fetched Nov 12, 2026
- CREATE: Art for Children With CancerNA · RECRUITING · started Jun 4, 2024ClinicalTrials.gov NCT06342453 · fetched Nov 12, 2026
- EMBRACE: Exercising TogetherPHASE2 · RECRUITING · started Apr 18, 2024ClinicalTrials.gov NCT06049355 · fetched Nov 12, 2026
- Use Of Indocyanine Green In Pancreas SurgeryRECRUITING · started Feb 29, 2024ClinicalTrials.gov NCT06084013 · fetched Nov 12, 2026
- Observational Study of Sex Differences in Symptoms During Immune Checkpoint Inhibitor Treatment for People With CancerRECRUITING · started Sep 15, 2023ClinicalTrials.gov NCT06562777 · fetched Nov 12, 2026
- Improving Decision-Making Encounters in Lung Cancer Using a Low-Literacy Conversation ToolNA · ACTIVE_NOT_RECRUITING · started Oct 31, 2022ClinicalTrials.gov NCT05407168 · fetched Nov 12, 2026
- Entrectinib in Combination With ASTX727 for the Treatment of Relapsed/Refractory TP53 Mutated Acute Myeloid LeukemiaPHASE1 · ACTIVE_NOT_RECRUITING · started Oct 28, 2022ClinicalTrials.gov NCT05396859 · fetched Nov 12, 2026
- Standard Verbal Counseling With or Without a Pictorial Educational Tool for the Reduction of Psychological Morbidity in Patients With Stage 0-IIIA Breast Cancer Receiving Radiation Therapy, COPE StudyNA · ACTIVE_NOT_RECRUITING · started Mar 18, 2022ClinicalTrials.gov NCT04993313 · fetched Nov 12, 2026
- Establishing a ctDNA Biomarker to Improve Organ Preserving Strategies in Patients With Rectal CancerRECRUITING · started Sep 3, 2021ClinicalTrials.gov NCT05081024 · fetched Nov 12, 2026
- Targeted Pathway Inhibition in Patients With Pancreatic CancerEARLY_PHASE1 · RECRUITING · started Aug 1, 2019ClinicalTrials.gov NCT04005690 · fetched Nov 12, 2026
- Feasibility of FMISO in Brain TumorsPHASE2 · RECRUITING · started Jun 1, 2019ClinicalTrials.gov NCT03649880 · fetched Nov 12, 2026
- Gadolinium and Ferumoxytol MRI in Diagnosing Patients With Abnormalities in the Central Nervous SystemPHASE2 · RECRUITING · started Oct 6, 2017ClinicalTrials.gov NCT03270059 · fetched Nov 12, 2026
- Enzalutamide and Cabazitaxel in Treating Patients With Metastatic, Castration-Resistant Prostate CancerPHASE1_PHASE2 · ACTIVE_NOT_RECRUITING · started Aug 13, 2015ClinicalTrials.gov NCT02522715 · fetched Nov 12, 2026